Chemotherapy in Combination With Immune Checkpoint Inhibitors for the First-Line Treatment of Patients With Advanced Non-small Cell Lung Cancer: A Systematic Review and Literature-Based Meta-Analysis

Background: Checkpoint inhibitors plus platinum-based chemotherapy have shown superiority compared to chemotherapy alone as first-line therapy in advanced non–small cell lung carcinoma (NSCLC). To evaluate the relative benefit in term of Overall Survival (OS) and Progression-free Survival (PFS) of c...

Descripción completa

Detalles Bibliográficos
Autores principales: Addeo, Alfredo, Banna, Giuseppe Luigi, Metro, Giulio, Di Maio, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478036/
https://www.ncbi.nlm.nih.gov/pubmed/31058078
http://dx.doi.org/10.3389/fonc.2019.00264

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478036/
https://www.ncbi.nlm.nih.gov/pubmed/31058078
http://dx.doi.org/10.3389/fonc.2019.00264

Ejemplares similares